ATE123529T1 - Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung. - Google Patents

Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.

Info

Publication number
ATE123529T1
ATE123529T1 AT90104500T AT90104500T ATE123529T1 AT E123529 T1 ATE123529 T1 AT E123529T1 AT 90104500 T AT90104500 T AT 90104500T AT 90104500 T AT90104500 T AT 90104500T AT E123529 T1 ATE123529 T1 AT E123529T1
Authority
AT
Austria
Prior art keywords
derivatives
new compounds
substances
production
pharmaceutically acceptable
Prior art date
Application number
AT90104500T
Other languages
English (en)
Inventor
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Shigehiro Takase
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898905817A external-priority patent/GB8905817D0/en
Priority claimed from GB898920485A external-priority patent/GB8920485D0/en
Priority claimed from GB898921078A external-priority patent/GB8921078D0/en
Priority claimed from GB898922164A external-priority patent/GB8922164D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE123529T1 publication Critical patent/ATE123529T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90104500T 1989-03-14 1990-03-09 Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung. ATE123529T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898905817A GB8905817D0 (en) 1989-03-14 1989-03-14 Fr901277 substance,process for preparation thereof and use thereof
GB898920485A GB8920485D0 (en) 1989-09-11 1989-09-11 Fr901278 substance,process for preparation thereof and use thereof
GB898921078A GB8921078D0 (en) 1989-09-18 1989-09-18 Fr901277 substance,process for preparation thereof and use thereof
GB898922164A GB8922164D0 (en) 1989-10-02 1989-10-02 Fr 901277 substance,derivatives thereof,processes for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
ATE123529T1 true ATE123529T1 (de) 1995-06-15

Family

ID=27450289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104500T ATE123529T1 (de) 1989-03-14 1990-03-09 Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.

Country Status (17)

Country Link
US (2) US5021240A (de)
EP (1) EP0387712B1 (de)
JP (1) JP2811881B2 (de)
KR (1) KR900014600A (de)
CN (1) CN1046938A (de)
AT (1) ATE123529T1 (de)
AU (1) AU628938B2 (de)
CA (1) CA2012074A1 (de)
DE (1) DE69019848T2 (de)
DK (1) DK0387712T3 (de)
ES (1) ES2072934T3 (de)
FI (1) FI901237A7 (de)
HU (1) HUT56395A (de)
IL (1) IL93548A (de)
NO (1) NO901160L (de)
PH (1) PH27266A (de)
PT (1) PT93427A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403605A4 (en) * 1988-09-09 1991-08-21 Univ Kentucky Res Found Elastase inhibiting polymers and methods
GB9014546D0 (en) * 1990-06-29 1990-08-22 Fujisawa Pharmaceutical Co Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
DK0519354T3 (da) * 1991-06-18 1998-01-12 Fujisawa Pharmaceutical Co Profylaktisk/terapeutisk præparat indeholdende WS7622A til forebyggelse eller behandling af dissemineret intravaskulær koagulation, kronisk luftvejsinfektionssygdom eller kronisk bronkitis
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
WO1999043352A1 (en) * 1998-02-24 1999-09-02 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CA2387199A1 (en) * 1999-10-12 2001-04-19 Fujisawa Pharmaceutical Co., Ltd. Remedies for intractable wound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD84898A (de) *
DE1132925B (de) * 1960-02-19 1962-07-12 Bayer Ag Loesungsvermittler fuer wasserschwerloesliche organische Verbindungen
US4537770A (en) * 1982-03-24 1985-08-27 Eli Lilly And Company A41030 antibiotics
US4695545A (en) * 1982-03-24 1987-09-22 Eli Lilly And Company Culture and process for producing A41030 antibiotics
US4596822A (en) * 1984-08-20 1986-06-24 Georgia Tech Research Corporation Heterocyclic inhibitors of serine proteases
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
CA2012074A1 (en) 1990-09-14
AU628938B2 (en) 1992-09-24
NO901160L (no) 1990-09-17
FI901237A0 (fi) 1990-03-13
AU5116890A (en) 1990-09-20
HUT56395A (en) 1991-08-28
JP2811881B2 (ja) 1998-10-15
KR900014600A (ko) 1990-10-24
FI901237A7 (fi) 1990-09-15
PT93427A (pt) 1990-11-07
NO901160D0 (no) 1990-03-13
DE69019848D1 (de) 1995-07-13
IL93548A (en) 1994-10-07
JPH03218387A (ja) 1991-09-25
CN1046938A (zh) 1990-11-14
EP0387712B1 (de) 1995-06-07
DK0387712T3 (da) 1995-08-14
IL93548A0 (en) 1990-11-29
EP0387712A1 (de) 1990-09-19
HU901427D0 (en) 1990-06-28
US5021240A (en) 1991-06-04
DE69019848T2 (de) 1995-12-07
US5167958A (en) 1992-12-01
ES2072934T3 (es) 1995-08-01
PH27266A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
ATE139232T1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
ATE125550T1 (de) Polypeptid und verfahren zu dessen herstellung.
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
ATE131173T1 (de) Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
ATE24933T1 (de) Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
AU8912891A (en) Biologically active amines
FI102547B (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä
ATE123529T1 (de) Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.
SE9703056L (sv) Klavulansyrasalter, förfarande för framställning därav och farmaceutiska kompositioner innehållande dem
DE68916659D1 (de) WS-9326 A, WS-9326B und deren Derivate.
ATE138074T1 (de) Disulfat von ws-7622a, verfahren zur herstellung und benutzung
DE3750396D1 (de) Optisch aktive 2,3-Dihydrobenzoxazinderivate und Verfahren zu deren Herstellung.
MX9305997A (es) 6-heterociclic-4-amino-1, 2, 2a, 3, 4, 5-hexahidrobenz[cd]indoles yprocedimiento para su preparacion.
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
ATE111092T1 (de) Antibiotikum a80915 und verfahren zu seiner herstellung.
ATE118780T1 (de) Antibiotika und verfahren zu deren herstellung.
ATE55153T1 (de) Ws-7739-verbindungen, deren herstellung und deren pharmazeutische zusammensetzung.
ATE124945T1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.
DE69011952D1 (de) Physiologisch aktive Verbindungen SN-198C sowie Verfahren und Bakterien zu deren Herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee